Edap Tms (NASDAQ:EDAP) Upgraded to “Hold” by StockNews.com

Edap Tms (NASDAQ:EDAP) was upgraded by stock analysts at StockNews.com from a “sell” rating to a “hold” rating in a note issued to investors on Tuesday.

Separately, HC Wainwright restated a “buy” rating and issued a $19.00 price target on shares of Edap Tms in a research report on Friday, May 17th.

Edap Tms Stock Performance

EDAP opened at $5.25 on Tuesday. The business’s 50 day moving average is $6.04 and its 200-day moving average is $6.35. The stock has a market cap of $194.78 million, a PE ratio of -9.72 and a beta of 0.45. The company has a current ratio of 2.62, a quick ratio of 2.00 and a debt-to-equity ratio of 0.08. Edap Tms has a twelve month low of $3.60 and a twelve month high of $9.53.

Edap Tms (NASDAQ:EDAP) last announced its earnings results on Thursday, May 16th. The medical equipment provider reported ($0.13) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.03). Edap Tms had a negative return on equity of 31.44% and a negative net margin of 30.12%. The firm had revenue of $16.13 million for the quarter, compared to the consensus estimate of $16.22 million. On average, analysts predict that Edap Tms will post -0.51 earnings per share for the current year.

Hedge Funds Weigh In On Edap Tms

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Virtu Financial LLC acquired a new stake in shares of Edap Tms in the 1st quarter valued at $82,000. Miracle Mile Advisors LLC acquired a new position in Edap Tms during the 1st quarter worth $136,000. Roubaix Capital LLC acquired a new position in Edap Tms during the 1st quarter worth $169,000. Finally, Rock Springs Capital Management LP lifted its position in Edap Tms by 14.6% during the 3rd quarter. Rock Springs Capital Management LP now owns 1,360,000 shares of the medical equipment provider’s stock worth $9,547,000 after acquiring an additional 173,700 shares during the last quarter. 62.74% of the stock is currently owned by hedge funds and other institutional investors.

Edap Tms Company Profile

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.